Sintx Technologies (SINT) EBT Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.39% |
| Dec 31, 2025 | -5.04% |
| Sep 30, 2025 | -7.74% |
| Jun 30, 2025 | 10.46% |
| Mar 31, 2025 | -31.69% |
| Dec 31, 2024 | -11.31% |
| Sep 30, 2024 | -33.96% |
| Jun 30, 2024 | -24.73% |
| Mar 31, 2024 | 11.47% |
| Dec 31, 2023 | -17.08% |
| Sep 30, 2023 | -1.46% |
| Jun 30, 2023 | -2.40% |
| Mar 31, 2023 | 39.06% |
| Dec 31, 2022 | -14.77% |
| Sep 30, 2022 | -12.87% |
| Jun 30, 2022 | -8.08% |
| Mar 31, 2022 | -40.92% |
| Dec 31, 2021 | -13.68% |
| Sep 30, 2021 | 14.70% |
| Jun 30, 2021 | 15.37% |
| Mar 31, 2021 | 4.92% |
| Dec 31, 2020 | 6.81% |
| Sep 30, 2020 | 24.79% |
| Jun 30, 2020 | 7.45% |
| Mar 31, 2020 | 17.26% |
| Dec 31, 2019 | 36.62% |
| Sep 30, 2019 | 21.76% |
| Jun 30, 2019 | 43.99% |
| Mar 31, 2019 | 19.14% |
| Dec 31, 2018 | -29.15% |
| Sep 30, 2018 | -4.79% |
| Jun 30, 2018 | 6.58% |
| Mar 31, 2018 | 0.27% |